You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
ABPA in adulthood: a CFTR-related disorder
  1. P Lebecque1,
  2. X Pepermans2,
  3. E Marchand3,
  4. A Leonard1,
  5. T Leal2
  1. 1Pediatric Pulmonology & Cystic Fibrosis Unit, Cliniques Universitaires St Luc Université de Louvain, Belgium
  2. 2Department of Genetics, Université de Louvain, Cliniques St Luc, Brussels, Belgium
  3. 3Department of Respiratory Diseases, Université de Louvain, Cliniques de Mont-Godinne, Yvoir, Belgium
  1. Correspondence to Patrick Lebecque, Pediatric Pulmonology & Cystic Fibrosis Unit, Cliniques Universitaires St Luc Université de Louvain, 10 avenue Hippocrate, 1200 Brussels, Belgium; patrick_lebecque{at}hotmail.com

https://doi.org/10.1136/thx.2010.145862

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In Western countries, allergic bronchopulmonary aspergillosis (ABPA) in childhood is very unusual beyond the context of cystic fibrosis (CF). It is presumed to be different in adulthood, although three studies1–3 reported an increased frequency of cystic fibrosis transmembrane conductance regulator (CFTR) mutations in adults with ABPA. Out of the 63 patients investigated in these studies, none was reported as pancreatic insufficient, all had sweat chloride values <60 mmol/l, only two carried the intron 8 splice variant 5T and a single patient was found to be compound heterozygous for two CFTR mutations. However, Miller et al studied only 10 patients and did not sequence all CFTR exons, while the two other reports, including one from our institution, were hampered by the small number of mutations initially looked for …

    View Full Text

    Footnotes

    • Competing interests None.

    • Patient consent Obtained.

    • Ethics approval This study was conducted with the approval of the Ethics Committee of the Cliniques Universitaires de Mont-Godinne.

    • Provenance and peer review Not commissioned; not externally peer reviewed.